Knockdown of BTB domain and CNC homolog 1 (BACH1) impedes Polo-like kinase 1 (PLK1)-induced phenotype in melanoma.
<p><b>(A and B)</b> Immunoblots for the expression of BACH1 in 2D-monolayer (A) and 3D-tumorsphere (B) of mouse melanoma cells (mMC) and mouse melanoma with Plk1 knock-in (mMPI) cells. <b>(C)</b> Immunoblots of BACH1 protein in nucleus and cytosol of mMC and mMPI cells....
Gorde:
| Egile nagusia: | Fengyi Mao (15073242) (author) |
|---|---|
| Beste egile batzuk: | Sai Wu (6096290) (author), Derek B. Allison (15141675) (author), Daheng He (9189701) (author), Yifan Kong (4458616) (author), Chaohao Li (15141681) (author), Zhiguo Li (431917) (author), Yanquan Zhang (14930570) (author), Xinyi Wang (559030) (author), Qiongsi Zhang (2818111) (author), Chi Wang (131921) (author), Xiaoqi Liu (45630) (author) |
| Argitaratua: |
2025
|
| Gaiak: | |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak
-
BTB domain and CNC homolog 1 (BACH1) is stabilized by Polo-like kinase 1 (PLK1).
nork: Fengyi Mao (15073242)
Argitaratua: (2025) -
Polo-like kinase 1 (PLK1) is involved in melanoma progression.
nork: Fengyi Mao (15073242)
Argitaratua: (2025) -
Polo-like kinase 1 (PLK1) induces Vemurafenib resistance in melanoma.
nork: Fengyi Mao (15073242)
Argitaratua: (2025) -
Inhibition of Polo-like kinase 1 (PLK1) synergizes with Vemurafenib in the treatment of melanoma.
nork: Fengyi Mao (15073242)
Argitaratua: (2025) -
Overexpressed Polo-like kinase 1 (PLK1) promotes metastasis and metabolic reprogramming in melanoma.
nork: Fengyi Mao (15073242)
Argitaratua: (2025)